| Product Name | Ketoconazole-d3 |
| Product Code | DA-K004-t |
| Chemical name | Ketoconazole-d3 |
| Synonyms | rel-1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]ethanone-d3; cis-1-Acetyl-d3-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; (+/-)-Ketocozole-d3; Brizoral-d3; Fungarest-d3; Fungoral-d3; Ketoderm-d3; Ketoisdin-d3; Ketozoral-d3; Nizoral-d3; Nizral-d3; Onofin K-d3; Orifungal M-d3; Panfungol-d3; R 41400-d3; |
| Impurity | NA |
| CAS Number | 1217766-70-5 |
| Alternate CAS # | NA |
| Molecular form | C26H25D3Cl2N4O4 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 534.45 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | aromatics,heterocycles,enzyme inhibitors,stable isotopes,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | Ketoconazole-d3 is the labeled analogue of Ketoconazole, which inhibits cytochrome P-450 dependent steps in the biosynthesis of steroid hormones in vivo. Antimetastatic and antineoplastic activity. Orally active 5-lipoxygenase and thromboxane synthase inhibitor. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
